SCM
TECH icon

Sandler Capital Management’s Bio-Techne TECH Stock Holding History

Sandler Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-39,500
Closed -$2.2M – 192
2025
Q3 		$2.2M Sell
39,500
-7,800
-16% -$418K 0.65% 60
2025
Q2 		$2.43M Buy
+47,300
New +$2.38M 0.66% 60

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Sandler Capital Management's TECH Position: Q1 2026 in Review

Sandler Capital Management increased its Bio-Techne (TECH) stake by 16% in Q1 2026, buying an estimated $150K and bringing the position to 17,936 shares worth $937K. The position accounts for 0.49% of the portfolio, ranked #77.

Sandler Capital Management first reported a position in TECH in Q2 2016 and has held it in 35 quarters since. The position peaked at $33.3M in Q3 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Sandler Capital Management held 17,936 shares of Bio-Techne worth $937K as of Q1 2026.
  • Sandler Capital Management bought 2,493 Bio-Techne shares in Q1 2026, an estimated $150K.
  • Bio-Techne made up 0.49% of Sandler Capital Management's portfolio in Q1 2026, its #77 holding.
  • Sandler Capital Management first reported a position in Bio-Techne in Q2 2016 and has held it in 35 quarters since.
  • Sandler Capital Management's Bio-Techne position peaked at $33.3M in Q3 2021.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Sandler Capital Management's 13F filing for Q1 2026, filed 15 May 2026.